ACCELERON PHARMA INC. Proceeds from Issuance Initial Public Offering
ACCELERON PHARMA INC. reported Proceeds from Issuance Initial Public Offering of -$47.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2016-02-25
- ACCELERON PHARMA INC. proceeds from issuance initial public offering for the quarter ending 2015-12-31 was -$47.00K.
- ACCELERON PHARMA INC. proceeds from issuance initial public offering for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- ACCELERON PHARMA INC. proceeds from issuance initial public offering for the quarter ending 2015-06-30 was $0.00.
- ACCELERON PHARMA INC. proceeds from issuance initial public offering for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- ACCELERON PHARMA INC. proceeds from issuance initial public offering for fiscal 2015 was -$47.00K, a 100.04% decline from fiscal 2014.
- ACCELERON PHARMA INC. proceeds from issuance initial public offering for fiscal 2014 was $129.17M, a 48.78% increase from fiscal 2013.
- ACCELERON PHARMA INC. proceeds from issuance initial public offering for fiscal 2013 was $86.83M.
- ACCELERON PHARMA INC. proceeds from issuance initial public offering for fiscal 2012 was $0.00.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|
| 2015-12-31 | -$47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$47.00K derived: sum of 2 quarters · filed 2016-02-25 | -$47.00K derived: sum of 3 quarters · filed 2016-02-25 | -$47.00K 10-K · filed 2016-02-25 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 derived: sum of 2 quarters · filed 2015-11-04 | $0.00 10-Q · filed 2015-11-04 | $0.00 derived: sum of 4 quarters · filed 2016-02-25 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $8.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-07 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $8.00K derived: sum of 3 quarters · filed 2016-02-25 | $8.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $8.00K derived: sum of 2 quarters · filed 2016-02-25 | $8.00K derived: sum of 3 quarters · filed 2016-02-25 | $129.17M 10-K · filed 2016-02-25 |
| 2014-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $8.00K derived: sum of 2 quarters · filed 2015-11-04 | $129.17M 10-Q · filed 2015-11-04 | $128.59M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $129.17M 10-Q · filed 2015-08-06 | $128.59M derived: sum of 3 quarters · filed 2016-02-25 | $215.99M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $129.17M 10-Q · filed 2015-05-07 | $128.59M derived: sum of 2 quarters · filed 2016-02-25 | $215.99M derived: sum of 3 quarters · filed 2016-02-25 | |
| 2013-12-31 | -$581.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $86.83M derived: sum of 2 quarters · filed 2016-02-25 | $86.83M 10-K · filed 2016-02-25 | |
| 2013-09-30 | $87.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $87.41M 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-12 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-02 |